ArticleCancer cell2018

Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.

Pei-Chih Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.